Clinical Trial Support

At Colbert et al., we partner with biotech and pharma sponsors to streamline every phase of your clinical program. Acting as the key liaison between investigative sites, sponsors, CROs, and regulatory bodies, we shape clinical development plans and help support the day-to-day operations to ensure protocol fidelity and on-time delivery. Our scientific communication strategy amplifies your data, through scientific posters, conference presentations, or manuscripts under review, while our targeted site-engagement initiatives boost patient enrollment rates and retention. From feasibility assessments to final study reports, Colbert et al. drives efficiency, quality, and impact in your clinical trials.

See samples of our previous projects below.

A clear glass beaker with colorful test tubes inside, placed on a yellow surface against a plain background.

Phase II

An Exploratory Study to Evaluate Attention Biases in Adults With Multiple Sclerosis, Breast Cancer, and Lung Cancer (NCT06136923)
A completed, multicenter feasibility trial (Oct 2023–Apr 2024; N=194) assessing CT-100-D-004’s Digital Neuro-activation and Modulation (DiNaMo) components to target attention biases in adults with MS, breast cancer, and lung cancer.

Colbert et al. role:
• Developed and executed the overall scientific communication strategy
• Secured and prepared ASCO conference presentations
• Designed and produced study posters for major meetings
• Managed manuscript development and data analysis

A female medical professional using a smartphone, wearing a white coat with a stethoscope around her neck.

Phase III

Study of Two Prescription Digital Therapeutics as an Adjunct to Standard-of-Care Antipsychotic Therapy in Adult and Late-Adolescent Participants with Experiential Negative Symptoms of Schizophrenia (NCT05838625)
A Phase 3, randomized, multicenter, 16-week trial evaluating the efficacy and safety of two prescription digital therapeutics in addition to standard antipsychotic care for experiential negative symptoms of schizophrenia.

Colbert et al. role:
• Served as the primary liaison between investigative sites, the sponsor (Click Therapeutics) and the CRO
• Oversaw sponsor-level clinical development strategy and managed day-to-day clinical operations
• Coordinated cross-functional communication to maintain protocol fidelity and timelines leading to increased site engagement and patient enrollment